Financiere des Professionnels - Fonds d'investissement inc.
Position in MRK — Merck & Co., Inc.
CIK 1996846
MONTREAL, A8
Position in MRK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,965,534
+$536,061 QoQ
Shares Held
93,117
-2.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#684
of 3,769 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financiere des Professionnels - Fonds d'investissement inc. holds $56,644,054 across 7 Drug Manufacturers - General names. MRK ranks #3 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
58,412 | $14,698,795 | |
| 2 | JNJ |
Johnson & Johnson
|
51,324 | $13,034,755 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
93,117 | $11,965,534 | |
| 4 | LLY |
ELI LILLY & Co
|
7,894 | $9,468,301 | |
| 5 | PFE |
Pfizer Inc
|
201,100 | $4,842,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,638 | $2,354,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,850 | $279,457 |
All Filings in MRK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,965,534 | 93,117 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $11,429,473 | 95,016 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $7,711,768 | 73,264 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,339,794 | 63,622 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $2,162,730 | 27,321 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $107,712 | 1,200 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||